PAIGE LEWLESS: Open Payments
NPI 1134709769 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,610 in 114 payments from 18 companies in 2025. Trend: 2023 $1,261 · 2024 $2,231 · 2025 $2,610
Food & beverage: $2,595Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $678 |
| UCB, Inc. | 18 | $475 |
| E.R. Squibb & Sons, L.L.C. | 22 | $295 |
| Amgen Inc. | 12 | $246 |
| Novartis Pharmaceuticals Corporation | 13 | $208 |
| ANI Pharmaceuticals, Inc. | 9 | $193 |
| Janssen Scientific Affairs, LLC | 1 | $134 |
| Mallinckrodt Hospital Products Inc. | 1 | $77 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Genentech USA, Inc. | 2 | $57 |
Products named: RINVOQ, Bimzelx, ORENCIA, OTEZLA, PURIFIED CORTROPHIN GEL, SKYRIZI, COSENTYX, TREMFYA.
Industry payments across NV — which companies pay providers there.
